Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-26 @ 2:54 AM
Study NCT ID:
NCT04284202
Status:
UNKNOWN
Last Update Posted:
2020-02-25
First Post:
2020-02-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC
Sponsor:
The Affiliated Hospital of Qingdao University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-23
First Submit QC Date:
None
Study First Post Date:
2020-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-24
Last Update Post Date:
2020-02-25
Last Update Post Date Type:
ACTUAL